ShareValue scores for NEOGEN.NSE: Valuation 21, Quality 48, Growth 37, Health 45.

NEOGEN.NSE
NSE

Neogen Chemicals Limited

₹2,031.50(+0.93%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-7% to 9%
Valuation
21
Overvalued
Price vs Value
Quality
48
Moderate
Business Strength
Growth
37
Weak
Revenue & Earnings
Health
45
Moderate
Financial Stability
Momentum
100
Bullish
Price Trend

Company Details

About

Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, suzuki coupling, hydrogenation, and biocatalysis. It serves pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, specialty polymers, vapor absorption chillers, emerging battery material applications, and other industries. The company also exports its products to 33 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026